An Antiviral Drug-Peramivir: Degradation and Identification of Impurities and the Endorsement of HPLC-MS Method.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of AOAC International"
DOI: 10.1093/jaoacint/qsad046
Abstract: BACKGROUND Peramivir, a neuraminidase inhibitor that serves as a transition-state analogue for influenza, inhibiting the formation of new viruses in infected cells and also been approved for intravenous administration. OBJECTIVE To validate the HPLC method… read more here.
Keywords: peramivir; hplc method; analysis; antiviral drug ... See more keywords
Single Dose IV Peramivir Treatment in Pediatric Influenza: Lack of Development of Influenza Virus Variants with Reduced Susceptibility to Peramivir
Sign Up to like & getrecommendations! Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.1353
Abstract: 1657. Single Dose IV Peramivir Treatment in Pediatric Influenza: Lack of Development of Influenza Virus Variants with Reduced Susceptibility to Peramivir Marie-Ève Hamelin, PhD; Yacine Abed, PhD; Julie Carbonneau, MSc; Rienk Jeeninga, PhD; Saskia Smits,… read more here.
Keywords: peramivir treatment; peramivir; treatment pediatric; dose peramivir ... See more keywords
Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2017 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2017.58.4.778
Abstract: Purpose Peramivir is the first intravenously administered neuramidase inhibitor for immediate delivery of an effective single-dose treatment in patients with influenza. However, limited data are available on intravenous (IV) peramivir treatment compared to oral oseltamivir… read more here.
Keywords: peramivir; treatment; oral oseltamivir; meta analysis ... See more keywords